Researchers at NewYork-Presbyterian Hospital's Weill Cornell Medical Center today announced initial phase II study results that suggest the addition of celecoxib (CELEBREX®) to paclitaxel/carboplatin, a common chemotherapy regimen, contributed to a clinical response in non-small cell lung cancer patients prior to surgery.

A large, randomized study of more than 3,000 New York City schoolchildren (mostly African-American and Hispanic) has shown for the first time that a school-based prevention program that teaches early adolescents drug refusal skills and other essential behaviors can significantly decrease binge drinking for as long as two years after the initial intervention.

A new book by a renowned professor of radiology clears up many common misconceptions about lung cancer and offers a strong basis for hope to those who may face the disease.

Married psychiatrists Drs. Philip Lee and Diane Rudolph say that just one percent of Americans are completely satisfied in their relationship with their spouse or partner. The 99 percent of Americans who are feeling somewhat dissatisfied with their significant other should use Valentine's Day to reflect on all the things they love about their mates and give their relationship a tune-up.

A team of surgeons and members of the breast cancer program of the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center is conducting a two-year pilot study of an innovative microsurgery technique coupled with imaging technology to not only prevent lymphedema but also potentially detect and treat it early.

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture — a severely blocked or narrowed bile duct.

For high-blood-pressure patients, preventing or reducing enlarged heart (left ventricular hypertrophy or LVH) reduces risk of heart failure. The study is published in the Sept. 4 Annals of Internal Medicine and led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.

A renowned hematologist and leader in academic medicine, Dr. Andrew I. Schafer has been named chairman of the Department of Medicine at Weill Cornell Medical College and physician-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Schafer, who will also be the E. Hugh Luckey Distinguished Professor of Medicine at Weill Cornell Medical College, joins the Medical Center from the University of Pennsylvania School of Medicine, where he was chairman of medicine.